Imlifidase
ATC L04AA41 · 4 markets · 5 records
AU 2 records · 2 strengths
- 12 mginjectionIDEFIRIX imlifidase 11 mg powder for concentrate for solution for infusion
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
GB 1 records · 1 strengths
- 11 mginjectionIdefirix 11mg powder for concentrate for solution for infusion vials
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 strengths
- 11 mginjectionIDEFIRIX 11 mg, poudre pour solution à diluer pour perfusion
| Strength / form / release | GB | AU | EU | FR |
|---|---|---|---|---|
| 11 mg injection | Idefirix 11mg powder for concentrate for solution for infusion vials | IDEFIRIX 11 mg, poudre pour solution à diluer pour perfusion | ||
| 12 mg injection | IDEFIRIX imlifidase 11 mg powder for concentrate for solution for infusion | |||
unknown | IDEFIRIX | IDEFIRIX |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.